Literature DB >> 2708349

Identification of a carcinoembryonic antigen gene family in the rat. Analysis of the N-terminal domains reveals immunoglobulin-like, hypervariable regions.

V Kodelja1, K Lucas, S Barnert, S von Kleist, J A Thompson, W Zimmermann.   

Abstract

The existence of a carcinoembryonic antigen (CEA)-like gene family in rat has been demonstrated through isolation and sequencing of the N-terminal domain exons of presumably five discrete genes (rnCGM1-5). This finding will allow for the first time the study of functional and clinical aspects of the tumor marker CEA and related antigens in an animal model. Sequence comparison with the corresponding regions of members of the human CEA gene family revealed a relatively low similarity at the amino acid level, which indicates rapid divergence of the CEA gene family during evolution and explains the lack of cross-reactivity of rat CEA-like antigens with antibodies directed against human CEA. The N-terminal domains of the rat CEA-like proteins show structural similarity to immunoglobulin variable domains, including the presence of hypervariable regions, which points to a possible receptor function of the CEA family members. Although so far only one of the five rat CEA-like genes could be shown to be transcriptionally active, multiple mRNA species derived from other members of the rat CEA-like gene family have been found to be differentially expressed in rat placenta and liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708349

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

2.  Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins.

Authors:  R K Williams; G S Jiang; K V Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic alpha-glycosides of mannose.

Authors:  H G Leusch; Z Drzeniek; Z Markos-Pusztai; C Wagener
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Characterization of murine carcinoembryonic antigen gene family members.

Authors:  F Rudert; A M Saunders; S Rebstock; J A Thompson; W Zimmermann
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

5.  Intra- and interspecies analyses of the carcinoembryonic antigen (CEA) gene family reveal independent evolution in primates and rodents.

Authors:  F Rudert; W Zimmermann; J A Thompson
Journal:  J Mol Evol       Date:  1989-08       Impact factor: 2.395

6.  Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV.

Authors:  G S Dveksler; M N Pensiero; C B Cardellichio; R K Williams; G S Jiang; K V Holmes; C W Dieffenbach
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Characterization and cellular localization of PSG in rat testis.

Authors:  L A Blomberg; S M Wu; G Dirami; M Dym; J Y Chou; W Y Chan
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

8.  Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.

Authors:  H Schrewe; J Thompson; M Bona; L J Hefta; A Maruya; M Hassauer; J E Shively; S von Kleist; W Zimmermann
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

9.  Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors.

Authors:  K Yokomori; M M Lai
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms.

Authors:  K McCuaig; M Rosenberg; P Nédellec; C Turbide; N Beauchemin
Journal:  Gene       Date:  1993-05-30       Impact factor: 3.688

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.